Neuroprotective mechanism of Kai Xin San: upregulation of hippocampal insulin-degrading enzyme protein expression and acceleration of amyloid-beta degradation
Open Access
- 1 January 2017
- journal article
- research article
- Published by Medknow in Neural Regeneration Research
- Vol. 12 (4) , 654-659
Abstract
Kai Xin San is a Chinese herbal formula composed of Radix Ginseng , Poria , Radix Polygalae and Acorus Tatarinowii Rhizome . It has been used in China for many years for treating amnesia. Kai Xin San ameliorates amyloid-β (Aβ)-induced cognitive dysfunction and is neuroprotective in vivo , but its precise mechanism remains unclear. Expression of insulin-degrading enzyme (IDE), which degrades Aβ, is strongly correlated with cognitive function. Here, we injected rats with exogenous Aβ42 (200 μM, 5 μL) into the hippocampus and subsequently administered Kai Xin San (0.54 or 1.08 g/kg/d) intragastrically for 21 consecutive days. Hematoxylin-eosin and Nissl staining revealed that Kai Xin San protected neurons against Aβ-induced damage. Furthermore, enzyme-linked immunosorbent assay, western blot and polymerase chain reaction results showed that Kai Xin San decreased Aβ42 protein levels and increased expression of IDE protein, but not mRNA, in the hippocampus. Our findings reveal that Kai Xin San facilitates hippocampal Aβ degradation and increases IDE expression, which leads, at least in part, to the alleviation of hippocampal neuron injury in rats.Keywords
This publication has 27 references indexed in Scilit:
- Meta-analysis of the insulin degrading enzyme polymorphisms and susceptibility to Alzheimer's diseaseNeuroscience Letters, 2013
- FTY720 (Fingolimod) Attenuates Beta-amyloid Peptide (Aβ42)-Induced Impairment of Spatial Learning and Memory in RatsJournal of Molecular Neuroscience, 2013
- Metabolism of amyloid β peptide and pathogenesis of Alzheimer’s diseaseProceedings of the Japan Academy, Series B, 2013
- Neonatal exposure to sevoflurane causes apoptosis and reduces nNOS protein expression in rat hippocampusMolecular Medicine Reports, 2012
- Concordant Association of Insulin Degrading Enzyme Gene (IDE) Variants with IDE mRNA, Aß, and Alzheimer's DiseasePLOS ONE, 2010
- Insulin degrading enzyme activity selectively decreases in the hippocampal formation of cases at high risk to develop Alzheimer's diseaseNeurobiology of Aging, 2007
- Structures of human insulin-degrading enzyme reveal a new substrate recognition mechanismNature, 2006
- The fate of Nissl-stained dark neurons following traumatic brain injury in rats: difference between neocortex and hippocampus regarding survival rateActa Neuropathologica, 2006
- Early-Onset Autosomal Dominant Alzheimer Disease: Prevalence, Genetic Heterogeneity, and Mutation SpectrumThe American Journal of Human Genetics, 1999
- Insulin-degrading Enzyme Regulates Extracellular Levels of Amyloid β-Protein by DegradationJournal of Biological Chemistry, 1998